Sign in
4

Changes in Ownership

UroGen Pharma Ltd. Filed Acc 0001209191-21-033402

Chief Financial Officer bought 2,500 shares at $15.85 ($39,625)

From the SEC's structured data for this filing

Trades in this filing

Henderson Molly · Chief Financial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2021-05-17 Purchase : show line 1 in the form +2,500 $15.85 $39,625 2,500 D
Open-market purchases · 2,500 sh · avg $15.85 · $39,625
Loading xslF345X03/doc4.xml…